UBcare. Co., Ltd.

KOSDAQ:A032620 Stock Report

Market Cap: ₩183.2b

UBcare Past Earnings Performance

Past criteria checks 0/6

UBcare's earnings have been declining at an average annual rate of -39.5%, while the Healthcare Services industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 11% per year.

Key information

-39.5%

Earnings growth rate

-39.4%

EPS growth rate

Healthcare Services Industry Growth16.7%
Revenue growth rate11.0%
Return on equity-1.0%
Net Margin-0.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Is UBcare (KOSDAQ:032620) A Risky Investment?

Nov 01
Is UBcare (KOSDAQ:032620) A Risky Investment?

UBcare (KOSDAQ:032620) Might Be Having Difficulty Using Its Capital Effectively

Aug 07
UBcare (KOSDAQ:032620) Might Be Having Difficulty Using Its Capital Effectively

These 4 Measures Indicate That UBcare (KOSDAQ:032620) Is Using Debt Reasonably Well

Jun 12
These 4 Measures Indicate That UBcare (KOSDAQ:032620) Is Using Debt Reasonably Well

UBcare. Co., Ltd. (KOSDAQ:032620) Held Back By Insufficient Growth Even After Shares Climb 34%

Feb 27
UBcare. Co., Ltd. (KOSDAQ:032620) Held Back By Insufficient Growth Even After Shares Climb 34%

Revenue & Expenses Breakdown

How UBcare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A032620 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24179,618-79180,0571,868
30 Jun 24170,577-68577,2631,810
31 Mar 24163,141-1,83975,3331,675
31 Dec 23154,041-55770,8561,663
30 Sep 23149,917-2,23569,2291,432
30 Jun 23146,4881,48064,8851,066
31 Mar 23140,3484,20160,902654
31 Dec 22133,3434,38657,000289
30 Sep 22127,9967,27454,8900
30 Jun 22120,3206,51952,8050
31 Mar 22114,7355,91448,93651
31 Dec 21111,76212,45046,4100
30 Sep 21107,2766,28043,7530
30 Jun 21106,4387,61542,4130
31 Mar 21104,62610,07342,8830
31 Dec 20104,8045,73141,6100
30 Sep 20107,4168,93942,8330
30 Jun 20108,7557,63442,1670
31 Mar 20111,6968,03240,8660
31 Dec 19110,8536,88841,8240
30 Sep 19110,0559,27441,1330
30 Jun 19108,1649,01941,3010
31 Mar 19104,9788,30740,5320
31 Dec 1899,8987,12339,6530
30 Sep 1895,3244,82837,4420
30 Jun 1889,8874,08536,4290
31 Mar 1885,2403,35234,8050
31 Dec 1782,0913,56034,1750
30 Sep 1776,6354,24332,8790
30 Jun 1773,8125,34631,7570
31 Mar 1769,8914,75231,4410
31 Dec 1668,2445,13330,2940
31 Mar 1662,2255,42628,8360
31 Dec 1559,4314,87128,5070
30 Sep 1556,1703,14627,8950
30 Jun 1552,6132,73228,3220
31 Mar 1552,4472,18128,8580
31 Dec 1455,7632,88529,1160
30 Sep 1463,8754,20228,7140
30 Jun 1465,3652,81230,7190
31 Mar 1464,7641,14631,9190

Quality Earnings: A032620 is currently unprofitable.

Growing Profit Margin: A032620 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A032620 is unprofitable, and losses have increased over the past 5 years at a rate of 39.5% per year.

Accelerating Growth: Unable to compare A032620's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A032620 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (20.4%).


Return on Equity

High ROE: A032620 has a negative Return on Equity (-1.03%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 03:59
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

UBcare. Co., Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Song-hyup HanDaishin Securities Co. Ltd.
Sang-Hun LeeiM Securities
Ju-Hong ChoeLS Securities Co., Ltd.